|
1
|
Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.
|
Cancer Res
|
2007
|
5.12
|
|
2
|
Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.
|
Proc Natl Acad Sci U S A
|
2008
|
3.43
|
|
3
|
Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters!
|
World J Surg
|
2007
|
2.21
|
|
4
|
An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.
|
Mol Cancer Ther
|
2008
|
2.21
|
|
5
|
Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions.
|
Gut
|
2012
|
1.55
|
|
6
|
DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS.
|
Nat Struct Mol Biol
|
2010
|
1.49
|
|
7
|
Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer.
|
Cancer Biol Ther
|
2011
|
1.45
|
|
8
|
Reduced complication rate after modified binding purse-string-mattress sutures pancreatogastrostomy versus duct-to-mucosa pancreaticojejunostomy.
|
Surgeon
|
2013
|
1.41
|
|
9
|
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.
|
Cancer Biol Ther
|
2011
|
1.18
|
|
10
|
Transabdominal preperitoneal versus totally extraperitoneal repair of inguinal hernia: a meta-analysis of randomized studies.
|
Am J Surg
|
2013
|
1.11
|
|
11
|
German national case collection for familial pancreatic cancer (FaPaCa): ten years experience.
|
Fam Cancer
|
2011
|
1.06
|
|
12
|
Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
|
Am J Gastroenterol
|
2007
|
1.03
|
|
13
|
Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
|
World J Surg
|
2004
|
0.99
|
|
14
|
Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
|
Ann Surg
|
2005
|
0.98
|
|
15
|
Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value.
|
World J Surg
|
2009
|
0.92
|
|
16
|
Palladin mutation causes familial pancreatic cancer: absence in European families.
|
PLoS Med
|
2007
|
0.91
|
|
17
|
Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors.
|
J Clin Endocrinol Metab
|
2003
|
0.89
|
|
18
|
Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
|
J Clin Endocrinol Metab
|
2014
|
0.89
|
|
19
|
Microarray analysis reveals differential expression of benign and malignant pheochromocytoma.
|
Endocr Relat Cancer
|
2010
|
0.88
|
|
20
|
Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.
|
Fam Cancer
|
2010
|
0.88
|
|
21
|
LCN2 and TIMP1 as Potential Serum Markers for the Early Detection of Familial Pancreatic Cancer.
|
Transl Oncol
|
2013
|
0.88
|
|
22
|
Expression of the transcription factor snail and its target gene twist are associated with malignancy in pheochromocytomas.
|
Ann Surg Oncol
|
2009
|
0.88
|
|
23
|
Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.
|
Langenbecks Arch Surg
|
2011
|
0.88
|
|
24
|
Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target.
|
Neuroendocrinology
|
2007
|
0.87
|
|
25
|
RNASEL germline variants are associated with pancreatic cancer.
|
Int J Cancer
|
2005
|
0.86
|
|
26
|
PanIN-specific regulation of Wnt signaling by HIF2α during early pancreatic tumorigenesis.
|
Cancer Res
|
2013
|
0.86
|
|
27
|
Expression of hedgehog signalling pathway in anaplastic thyroid cancer.
|
Endocrine
|
2013
|
0.84
|
|
28
|
Low frequency of CHEK2 mutations in familial pancreatic cancer.
|
Fam Cancer
|
2006
|
0.84
|
|
29
|
Clinical impact of TP53 alterations in adrenocortical carcinomas.
|
Langenbecks Arch Surg
|
2011
|
0.84
|
|
30
|
Multimodal treatment of sporadic and inherited neuroendocrine tumors of the thymus.
|
Surgery
|
2008
|
0.83
|
|
31
|
Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors.
|
Langenbecks Arch Surg
|
2014
|
0.82
|
|
32
|
RIO kinase 3 acts as a SUFU-dependent positive regulator of Hedgehog signaling.
|
Cell Signal
|
2013
|
0.81
|
|
33
|
Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1.
|
Ann Surg
|
2013
|
0.81
|
|
34
|
Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases.
|
Neuroendocrinology
|
2015
|
0.81
|
|
35
|
Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity.
|
Pancreas
|
2011
|
0.81
|
|
36
|
Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problems.
|
Int J Mol Sci
|
2012
|
0.81
|
|
37
|
Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1.
|
Neuroendocrinology
|
2013
|
0.80
|
|
38
|
Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model of pancreatic cancer.
|
Langenbecks Arch Surg
|
2013
|
0.80
|
|
39
|
Outcome in patients with long-term treatment in a surgical intensive care unit.
|
Langenbecks Arch Surg
|
2012
|
0.79
|
|
40
|
Outcome of surgery for ileojejunal neuroendocrine tumors.
|
Surg Today
|
2012
|
0.78
|
|
41
|
Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomas.
|
Endocrine
|
2009
|
0.77
|
|
42
|
Corrigendum: Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1.
|
Nat Commun
|
2015
|
0.76
|
|
43
|
A Pancreatic Polypeptide-Producing Pancreatic Tumor Causing WDHA Syndrome.
|
Case Rep Gastroenterol
|
2008
|
0.76
|
|
44
|
Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1.
|
Neuroendocrinology
|
2015
|
0.76
|
|
45
|
Fast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: a case report.
|
J Med Case Rep
|
2008
|
0.75
|
|
46
|
Molecular Characterization and Pathogenesis of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
|
Eur Surg Res
|
2015
|
0.75
|
|
47
|
Shortness: an unknown phenotype of multiple endocrine neoplasia type 1.
|
Eur J Endocrinol
|
2013
|
0.75
|
|
48
|
Over-Expression of miRNA miR-7-5p is a Potential Biomarker in Neuroendocrine Neoplasia of the Small Intestine.
|
Neuroendocrinology
|
2017
|
0.75
|
|
49
|
Impact of CT-based diagnostic imaging on management and outcome of nonfunctioning pancreatic tumors.
|
Langenbecks Arch Surg
|
2011
|
0.75
|
|
50
|
Familial pancreatic cancer: current status.
|
Expert Opin Med Diagn
|
2007
|
0.75
|
|
51
|
Robotic-Assisted Approach Improves Vessel Preservation in Spleen-Preserving Distal Pancreatectomy.
|
Dig Surg
|
2016
|
0.75
|